Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection (Q24243146)

Europe PubMed Central

title

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection (English)

0 references

main subject

maternal health

0 references

HIV transmission

0 references

anti-retroviral agent

0 references

author

Nandi Siegfried

2

0 references

Jimmy Volmink

1

0 references

Peter Brocklehurst

4

0 references

Lize van der Merwe

object named as

Lize van der Merwe

Cochrane Database of Systematic Reviews

3

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

18-Month mortality and perinatal exposure to zidovudine in West Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Single-dose nevirapine and drug resistance: the more you look, the more you find

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

HIV transmission through breastfeeding: a study in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

AIDS across Europe, 1994-98: the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Multicenter review of protease inhibitors in 89 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Meeting international goals in child survival and HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

Risk factors for mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076--results and treatment recommendations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

[Clinical and laboratory evolution of children born to HIV positive mothers]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB2

7 January 2021

10.1002/14651858.CD003510.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3616938

3616938

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference